학술논문
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial
Document Type
Article
Author
Jansen, F.M.; Smits, L.J.T.; De Jong, D.J.; Hoentjen, F.; Van Linschoten, R.C.A.; Pauwels, R.W.M.; De Vries, A.C.; Van Der Woude, C.J.; West, R.L.; Kievit, W.; Boekema, P.J.; Bodelier, A.G.L.; Gisbertz, I.A.M.; Wolfhagen, F.H.J.; Römkens, T.E.H.; Lutgens, M.W.M.D.; Van Bodegraven, A.A.; Oldenburg, B.; Pierik, M.J.; Russel, M.G.V.M.; De Boer, N.K.; Mallant-Hent, R.C.; Ter Borg, P.C.J.; Van Der Meulen-De Jong, A.E.; Jansen, J.M.; Jansen, S.V.; Tan, A.C.I.T.L.; Van Noord, D.; Hoekstra, J.; Kamphuis, J.T.; Gorter, M.H.P.; Van Esch, A.A.J.
Source
In: Journal of Crohn's and Colitis . (Journal of Crohn's and Colitis, 1 November 2023, 17(11):1771-1780)
Subject
Language
English
ISSN
18764479
18739946
18739946